216 records found for: Title = Heart Disease Year =
Mahtta D, Virani SS. Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: can we identify those who derive the highest benefit? Journal of medical economics. 2020 Apr 29; 1-3.
Levy AE, Huang C, Huang A, Michael Ho P. Recent Approaches to Improve Medication Adherence in Patients with Coronary Heart Disease: Progress Towards a Learning Healthcare System. Current Atherosclerosis Reports. 2018 Jan 24; 20(1):5.
McSweeney JC, Cleves MA, Fischer EP, Pettey CM, Beasley B. Using the McSweeney Acute and Prodromal Myocardial Infarction Symptom Survey to Predict the Occurrence of Short-Term Coronary Heart Disease Events in Women. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2017 Nov 1; 27(6):660-665.
Heidenreich PA. Interventions Using the Electronic Medical Record to Improve Care of Patients with Heart Disease. Presented at: International Academy of Cardiology Annual World Congress on Heart Disease; 2015 Jul 27; Vancouver, Canada.
Damluji AA, Cohen ER, Rich MW, Forman DE. Insulin provision therapy and mortality in elderly patients with diabetes mellitus and stable ischemic heart disease: insights from BARI-2D trial. Presented at: American College of Cardiology Annual Scientific Session; 2015 Mar 17; San Diego, CA.
Laporta R, Anandam A, El-Solh AA. Screening for obstructive sleep apnea in veterans with ischemic heart disease using a computer-based clinical decision-support system. Clinical research in cardiology : official journal of the German Cardiac Society. 2012 Sep 1; 101(9):737-44.
Gopaldas RR, Chu D, Bakaeen FG. Acquired heart disease: Coronary insufficiency. In: Townsend, Jr. CM, Beauchamp RD, Evers BM, Mattox KL, editors. Sabiston Textbook of Surgery. 19 ed. Philadelphia, PA: Saunders; 2012. Chapter 60. 1650-1678 p.
Welles CC, Ku IA, Kwan DM, Whooley MA, Schiller NB, Turakhia MP. Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study. Journal of the American College of Cardiology. 2012 Feb 14; 59(7):673-80.
Welles CC, Na B, Whooley M, Turakhia M. CHADS2 Score Predicts Ischemic Stroke in the Absence of Atrial Fibrillation Among Patients With Coronary Heart Disease: Data from the Heart and Soul Study. Poster session presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 5; New Orleans, LA.
Owens DK. Comparative Effectiveness of Treatments for Stable Ischemic Heart Disease: Evaluating Effects in Subgroups and Accounting for Rapid Technological Advances. Presented at: National Institutes of Health / Agency for Healthcare Research and Quality Conference on Methodological Challenges in Comparative Effectiveness Research; 2010 Dec 2; Bethesda, MD.
Sanders GD, Powers B, Crowley M, Myers E, McBroom A, Musty M, Gray R. Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease: Identification of Future Research Needs from Comparative Effectiveness Review No. 18. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Nov 1. 6 p. Report No.: 10-EHC006-EF.
Duffy SA. Michigan Operating Engineers: Heart Disease and Cancer in the Making. Paper presented at: International Occupational Hygiene Association International Scientific Conference; 2010 Sep 28; Rome, Italy.
Sanders GD, Powers BJ, Powers BJ, Crowley M. Future Research Needs for Angiotensin Converting Enzyme (ACE) Inhibitors or Angiotensin II Recepton Blockers (ARBs) added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease. Rockville, MD: Agency for Healthcare Research and Quality; 2010 Sep 1. 1-10 p. Report No.: 18.
Duffy SA. Michigan Operating Engineers: Heart Disease and Cancer in the Making. Poster session presented at: University of Michigan School of Nursing Dean's Lecture and Research Day Conference; 2010 Apr 6; Ann Arbor, MI.
Axon RN, Zhao Y, Egede LE. Association of depressive symptoms with all-cause and ischemic heart disease mortality in adults with self-reported hypertension. American journal of hypertension. 2010 Jan 1; 23(1):30-7.
McSweeney JC, Pettey CM, Fischer EP, Spellman A. Going the distance: overcoming challenges in recruitment and retention of Black and White women in multisite, longitudinal study of predictors of coronary heart disease. Research in gerontological nursing. 2009 Oct 27; 2(4):256-64.
Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Annals of internal medicine. 2009 Oct 6; 151(7):483-95.
U. S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2009 Oct 6; 151(7):474-82.
Turakhia MP, McManus DD, Whooley MA, Schiller NB. Increase in end-systolic volume after exercise independently predicts mortality in patients with coronary heart disease: data from the Heart and Soul Study. European heart journal. 2009 Oct 1; 30(20):2478-84.
Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation. 2007 Jan 16; 115(2):173-9.
Chan PS, Hayward RA. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study. Journal of the American College of Cardiology. 2005 May 3; 45(9):1474-81.
Woodard LD, Kressin NR, Petersen LA. Is lipid-lowering therapy underused by African Americans at high risk of coronary heart disease within the VA health care system? American journal of public health. 2004 Dec 1; 94(12):2112-7.
Chan P, Hayward RA. Predicting 1-Year Mortality in Patients Receiving Implantable Cardioverter-Defibrillators for Congestive Heart Failure, Ischemic Heart Disease, and Ventricular Arrhythmias. Paper presented at: American Heart Association Annual Scientific Sessions; 2004 Nov 1; New Orleans, LA.
Chan P, Hayward RA. Mortality Reduction by Implantable Cardioverter-Defibrillators in VA Patients with Ischemic Heart Disease, Congestive Heart Failure, and a History of Ventricular Arrhythmias. Paper presented at: Heart Failure Society of America Annual Scientific Meeting; 2004 Sep 13; Toronto, Canada.
Pineros SL, Sales AE, Li Y, Sharp ND. Improving care to patients with ischemic heart disease: experiences in a single network of the Veterans Health Administration. Worldviews on evidence-based nursing / Sigma Theta Tau International, Honor Society of Nursing. 2004 Sep 1; 1(Suppl 1):S33-S40.
Egede LE, Nietert P, Zheng D. Depression is Associated with Increased Risk of Death from Coronary Heart Disease in Individuals with Diabetes. Paper presented at: Australian Diabetes Society Annual Meeting; 2004 Aug 1; Sydney, Australia.
Douglas M. Women and heart disease: A cross cultural study of symptom management. Paper presented at: Transcultural Nursing Society Annual Conference; 2004 Jun 15; Alicante, Spain.
Egede LE, Nietert P, Zheng D. Depression and Coronary Heart Disease Mortality in Individuals with Diabetes. Poster session presented at: American Diabetes Association Annual Scientific Session; 2004 Jun 4; Orlando, FL.
Rubins HB, Nelson DB, Noorbaloochi S, Nugent S. Effectiveness of lipid-lowering medications in outpatients with coronary heart disease in the Department of Veterans Affairs System. American Journal of Audiology. 2003 Nov 15; 92(10):1177-82.
Miller R. Underuse of cardioprotective medications in ischemic heart disease patients prior to acute myocardial infarction. Paper presented at: Society of General Internal Medicine Annual Meeting; 2003 May 1; Vancouver, Canada.
Woodard LD, Kressin NR, Petersen LA. Comparison of medication use in coronary heart disease patients with and without diabetes. Journal of general internal medicine. 2003 Jan 1; 18(Suppl 1):299-299.
Woodard LD, Kressin NR, Petersen LA. Examining disparities in cholesterol monitoring and treatment among veterans with coronary heart disease. Paper presented at: Kelsey Research Foundation Health Services and Outcomes Research Annual Conference; 2002 Nov 1; Houston, TX.
Biswas MS, Bastian LA. Risk factors for heart disease among women: Communicating probabilities of disease. Journal of clinical outcomes management : JCOM. 2002 Jun 1; 9(6):333-340.
Bibbins-Domingo K, Ansari M, Schiller N, Whooley M. B-type natriuretic peptide and exercise-induced ischemia among patients with stable coronary heart disease: The Heart and Soul Study. Paper presented at: Society of General Internal Medicine Annual Meeting; 2002 May 1; Atlanta, GA.
Ruo B, Whooley M. Predictors of quality of life in patients with coronary heart disease: The Heart and Soul Study. Paper presented at: Society of General Internal Medicine Annual Meeting; 2002 May 1; Atlanta, GA.
Natarajan S, Liao Y, Sinha D, Cao G, Lipsitz SR, McGee DL. Longstanding Diabetes Is Associated with Greater Risk for Coronary Heart Disease Mortality in Women than Prevalent Coronary Heart Disease. Paper presented at: American Heart Association Cardiovascular Disease Epidemiology and Prevention Annual Conference; 2002 Apr 4; Honolulu, HI.
Massie BM. Heart disease. In: Tierney LM, McPhee S, editors. Current Medical Diagnosis and Treatment. Norwalk, CT: Lange Medical Books; 2001.
Massie BM. Heart disease and the surgical patient. In: Way LE, editor. Current Surgical Diagnosis and Therapy. Norwalk, CT: Lange Medical Books; 2001.
Sloan K, Sales A, Pineros S, Rothendler J. Comparing process and outcomes measures in the evaluation of ischemic heart disease secondary prevention. Paper presented at: AcademyHealth Annual Research Meeting; 2001 Jun 12; Atlanta, GA.
Lemaitre R, Siscovick D, King I, Mozaffarian D, Kuller L, Tracy R. Plasma phospholipid n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and non-fatal myocardial infarction in older adults: the Cardiovascular Health Study. Paper presented at: American Heart Association Annual Scientific Sessions; 2001 Mar 15; San Antonio, TX.
Wilt T, Mac Donald, Nelson D, Pineros S. LDL cholesterol goals for secondary prevention of coronary heart disease. A systematic review of the evidence. Department of Veterans Affairs Office of Research and Development; 2001 Mar 1.
Sales A, Pineros S, Sloan K, Starks H. Lipid Measurement and Management among VA Patients with Ischemic Heart Disease. Paper presented at: VA HSR&D National Meeting; 2001 Feb 14; Washington, DC.
Whitsel E, Boyko E, Rautaharju P. QT interval prolongation and risk of primary cardiac arrest in diabetic patients without clinically recognized heart disease. Circulation. 2000 Sep 15; 101(6):25:716.
Every NR, Fihn SD, Sales AE, Keane A, Ritchie JR. Quality Enhancement Research Initiative in ischemic heart disease: a quality initiative from the Department of Veterans Affairs. QUERI IHD Executive Committee. Medical care. 2000 Jun 1; 38(6 Suppl 1):I49-59.
Sales A. Secondary prevention for Ischemic Heart Disease: Guideline concordance. Paper presented at: VA HSR&D National Meeting; 2000 Mar 22; Washington, DC.
Brown AI, Garber AM. A concise review of the cost-effectiveness of coronary heart disease prevention. The Medical Clinics of North America. 2000 Jan 1; 84(1):279-97, xi.
Brown A, Garber A. Cost effectiveness of coronary heart disease prevention strategies in adults. In: Mallarkey G, editor. Aspects of Hypertension Management. Auckland, New Zealand: Adis International Limited; 1999. 85-106 p.
Brown AD, Garber AM. Cost effectiveness of coronary heart disease prevention strategies in adults. Pharmacoeconomics. 1998 Jul 1; 14(1):27-48.